IgAN - IgA Nephropathy
5 clinical trials · Condition
◉ Watch IgAN - IgA Nephropathy
| Record | Firm | Date |
|---|---|---|
| First in Human Study to Assess Safety of VIS649 in Healthy Subjects (NCT03719443) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2018-10-09 |
| Assessing the Global Burden of IgA Nephropathy (IgAN) in Patients Receiving Hemodialysis: A Real-World Study Using DOPPS Data (NCT07607002) | Arbor Research Collaborative for Health | 1996-01-01 |
Track IgAN - IgA Nephropathy automatically
Every clearance here is in the API, with alerts when new ones post.